CAR T-Cell Therapy

CAR-T cell therapy can be a last hope for some pediatric patients and their families. Patrick Brown, director of the Pediatric Leukemia Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins explains the excitement about this new therapy, which patients are the best candidates and why Johns Hopkins Children’s Center is one of the few East Coast hospitals approved to provide this treatment.